SYNDROME DE DENYS - DRASH : A PROPOS DUN CAS
Journal: International Journal of Advanced Research (Vol.12, No. 09)Publication Date: 2024-09-15
Authors : N. Chriki H. Nassih R.El Qadiry A. Bourhouat; I. Ait Sab;
Page : 545-550
Keywords : Mutation Sexual Ambiguity Wilms Tumor Diffuse Mesangial Sclerosis;
Abstract
Denys-Drash syndrome (DDS) consists of a triad of pseudo-hermaphroditism, Wilms tumor and nephropathy. The condition may manifest as a complete triad or an incomplete form, with any or a combination of the above features. The characteristic glomerular abnormality of DDS is diffuse mesangial sclerosis.DDS is a spectrum of diseases with phenotypic heterogeneity. The clinical course is unpredictable despite a similar genotype.There is no single clinical guideline for the optimal management of patients with DDS, due to the impossibility of accurately predicting the course of each affected individual. Similarly, there is no consensus on the advisability of removing native kidneys in DDS patients with nephropathy that has progressed to End Stage Renal Disease. Ultimately, clinical practice is guided by the availability of resources.We report in this work a suspected case of DDS, which was lost within 24 hours of hospitalization.
Other Latest Articles
- TO ASSESS THE EFFECTIVENESS OF VIDEO ASSISTED TEACHING PROGRAMME ON KNOWLEDGE REGARDING IMPORTANCE OF UMBILICAL CORD BLOOD PRESERVATION FOR FUTURE TREATMENT MODALITIES AMONG EXPECTANT COUPLES AT SELECTED HOSPITALS
- STRATEGIC INTERPLAY IN GREEN SUPPLY CHAINS: GAME THEORETICAL INSIGHTS INTO PERFORMANCE, GREEN MARKETING
- HARNESSING THE POWER OF IOT AND FOG COMPUTING FOR ENHANCED PATIENT MONITORING IN CRITICAL CARE UNITS
- RENEWABLE ENERGY IN THE KINGDOM OF MOROCCO: EXPLORING THE IMPACT OF TECHNOLOGICAL INNOVATIONS ON CARBON DIOXIDE EMISSIONS
- Improve Care in Patients with Pancreatic Pathology |Biomedgrid
Last modified: 2024-10-18 15:09:09